The Overlooked Half of Formulation Supply
Active Pharmaceutical Ingredients get most of the attention in pharmaceutical procurement discussions, but excipients — the inactive substances that make up the bulk of most tablet and capsule formulations — represent a steady, recurring procurement category in their own right for EDCL.
What This Category Covers
- Binders — hold tablet ingredients together during compression
- Fillers/diluents — bulk out low-dose formulations to a workable tablet size
- Disintegrants — control how quickly a tablet breaks down after ingestion
- Coating agents — film coatings for taste-masking, moisture protection, or controlled release
Compliance Standard
Excipients follow the same pharmacopoeia compliance expectation as APIs — BP, USP, or IP grade material, with Certificates of Analysis for each batch and manufacturing site documentation demonstrating GMP-equivalent quality control, even though excipients themselves are typically lower regulatory risk than active ingredients.
Volume and Consistency Matter
Because excipients are consumed in larger bulk volumes relative to APIs, consistent batch-to-batch quality and reliable supply volume tend to weigh heavily in EDCL's supplier evaluation — a manufacturer who can guarantee consistent specification at production scale is often better positioned than one offering marginally better specification but less certain volume reliability.
